Improving cancer screening and genetic services for Black and Hispanic women
Bundled Multicancer Screening and Genetic Services Navigation to Improve Cancer Health Equity among Black and Hispanic Women
This study is working to help Black and Hispanic women get easier access to cancer screenings and genetic testing by providing friendly support in their own language, making it simpler for them to take care of their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11116110 on NIH RePORTER |
What this research studies
This research aims to enhance cancer health equity by addressing barriers to cancer screening and genetic testing among Black and Hispanic women. It employs a community-based bilingual navigation approach to connect these women with healthcare services, facilitating access to multicancer screening and risk assessment. By bundling these services, the project seeks to reduce the burden on patients while improving screening rates and overall health outcomes. The study will rigorously test the effectiveness of this navigation model in increasing access to necessary cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research are non-Hispanic Black and Hispanic women who are at risk for breast and colorectal cancers and face barriers to accessing healthcare.
Not a fit: Patients who do not identify as Black or Hispanic or who are not at risk for breast or colorectal cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce cancer-related deaths among Black and Hispanic women by improving access to timely screenings and genetic testing.
How similar studies have performed: Previous pilot studies have shown promising results in increasing cancer screening rates through similar navigation and bundling approaches, indicating potential for success in this larger trial.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: O'neill, Suzanne C. — Georgetown University
- Study coordinator: O'neill, Suzanne C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.